Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Helin

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Blood Pressure|July 1, 1997
Endothelin-1 in heart and pulmonary tissue in experimental heart failureM L Sirviö, K Helin, P Stewen, et al.
Virology|April 7, 1999
Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor proteinM Mannervik, S Fan, A C Ström, et al.
The EMBO Journal|November 15, 2001
Mad2 binding to Mad1 and Cdc20, rather than oligomerization, is required for the spindle checkpointL Sironi, M Melixetian, M Faretta, et al.
The EMBO Journal|January 16, 1999
Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localizationB O Petersen, J Lukas, C S Sørensen, et al.
Journal of Virology|December 1, 1993
Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1N Dyson, M Dembski, A Fattaey, et al.
Cell|July 24, 1992
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2FK Helin, J A Lees, M Vidal, et al.
The American Journal of Pathology|June 1, 1994
Time course of complement activation and inhibitor expression after ischemic injury of rat myocardiumA Väkevä, B P Morgan, I Tikkanen, et al.
The Journal of Biological Chemistry|February 7, 2001
E2F family members are differentially regulated by reversible acetylationG Marzio, C Wagener, M I Gutierrez, et al.
Genes & Development|July 15, 1997
Induction of DNA synthesis and apoptosis are separable functions of E2F-1A C Phillips, S Bates, K M Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complexK Hofland, B O Petersen, J Falck, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Blood Pressure|July 1, 1997
Endothelin-1 in heart and pulmonary tissue in experimental heart failureM L Sirviö, K Helin, P Stewen, et al.
Virology|April 7, 1999
Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor proteinM Mannervik, S Fan, A C Ström, et al.
The EMBO Journal|November 15, 2001
Mad2 binding to Mad1 and Cdc20, rather than oligomerization, is required for the spindle checkpointL Sironi, M Melixetian, M Faretta, et al.
The EMBO Journal|January 16, 1999
Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localizationB O Petersen, J Lukas, C S Sørensen, et al.
Journal of Virology|December 1, 1993
Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1N Dyson, M Dembski, A Fattaey, et al.
Cell|July 24, 1992
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2FK Helin, J A Lees, M Vidal, et al.
The American Journal of Pathology|June 1, 1994
Time course of complement activation and inhibitor expression after ischemic injury of rat myocardiumA Väkevä, B P Morgan, I Tikkanen, et al.
The Journal of Biological Chemistry|February 7, 2001
E2F family members are differentially regulated by reversible acetylationG Marzio, C Wagener, M I Gutierrez, et al.
Genes & Development|July 15, 1997
Induction of DNA synthesis and apoptosis are separable functions of E2F-1A C Phillips, S Bates, K M Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complexK Hofland, B O Petersen, J Falck, et al.
Pageof 8